These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22453589)

  • 21. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].
    Schellini SA; Matai O; Igami TZ; Padovani CR; Padovani CP
    Arq Bras Oftalmol; 2006; 69(1):23-6. PubMed ID: 16491229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin A in blepharospasm and hemifacial spasm.
    Behari M; Singh KK; Seshadri S; Prasad K; Ahuja GK
    J Assoc Physicians India; 1994 Mar; 42(3):205-8. PubMed ID: 7860509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
    Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
    Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of techniques of botulinum toxin injections for blepharospasm and hemifacial spasm.
    Sacramento DRC; Lima A; Maia DP; Cunningham M; Maciel RH; Camargos ST; Cardoso F
    Mov Disord; 2019 Sep; 34(9):1401-1403. PubMed ID: 31251420
    [No Abstract]   [Full Text] [Related]  

  • 26. [What to do in cases of inadequate effectiveness of botulinum toxin for the treatment of eyelid cramping?].
    Roggenkämper P
    Ophthalmologe; 2007 Sep; 104(9):763-6. PubMed ID: 17726608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of high-dose botulinum A toxin in benign essential blepharospasm: is too high too much?
    Pang AL; O'Day J
    Clin Exp Ophthalmol; 2006 Jul; 34(5):441-4. PubMed ID: 16872340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of botulinum toxin A for treatment of unilateral spasms of the eyelid and its prognosis.
    Xu YP; Shen J; Zhu QB; Gu J; Lin SZ; Fan JP
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2974-9. PubMed ID: 24254570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
    Thussu A; Barman CR; Prabhakar S
    Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases.
    Ortisi E; Henderson HW; Bunce C; Xing W; Collin JR
    Eye (Lond); 2006 Aug; 20(8):916-22. PubMed ID: 16531977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An internally controlled, double-blind comparison of the efficacy of onabotulinumtoxinA and abobotulinumtoxinA.
    Nettar KD; Yu KC; Bapna S; Boscardin J; Maas CS
    Arch Facial Plast Surg; 2011; 13(6):380-6. PubMed ID: 21690460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm.
    Jost WH; Kohl A
    J Neurol; 2001 Apr; 248 Suppl 1():21-4. PubMed ID: 11357234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of blepharospasm and facial hemispasm by injection of botulinum toxin].
    Saraux H
    J Fr Ophtalmol; 1988; 11(3):237-40. PubMed ID: 3418019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Costs and efficacy of type A botulinum toxin for the treatment of essential blepharospasm and hemifacial spasm].
    Lasalvia CG; Pereira Lde S; da Cunha MC; Kitadai SP
    Arq Bras Oftalmol; 2006; 69(5):701-5. PubMed ID: 17187139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial.
    Wickwar S; McBain H; Newman SP; Hirani SP; Hurt C; Dunlop N; Flood C; Ezra DG
    Trials; 2016 Mar; 17(1):129. PubMed ID: 26961367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study.
    Rollnik JD; Matzke M; Wohlfarth K; Dengler R; Bigalke H
    Eur Neurol; 2000; 43(1):9-12. PubMed ID: 10601802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term stable efficacy of botulinum toxin A in facial movement disorders with no need for increasing dose.
    Badarny S; Ibrahim R; Susel Z; Zaina A; Nasar R; Badarny Y
    Medicine (Baltimore); 2021 Jun; 100(25):e26481. PubMed ID: 34160460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
    Ho MC; Hsu WC; Hsieh YT
    JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blepharospasm and hemifacial spasm: long-term treatment with botulinum toxin.
    Gil Polo C; Rodríguez Sanz MF; Berrocal Izquierdo N; Castrillo Sanz A; Gutiérrez Ríos R; Zamora García MI; Mendoza Rodríguez A; Duarte García-Luis J
    Neurologia; 2013 Apr; 28(3):131-6. PubMed ID: 22652139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.